Deutsche Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $43.4K | Sell |
|
|||||
|
2024
Q4 | $234K | Buy |
|
|||||
|
2024
Q3 | $104K | Buy |
|
|||||
|
2024
Q2 | $53.6K | Sell |
|
|||||
|
2024
Q1 | $93K | Sell |
|
|||||
|
2023
Q4 | $61.6K | Hold |
|
|||||
|
2023
Q3 | $43.9K | Hold |
|
|||||
|
2023
Q2 | $92.3K | Sell |
|
|||||
|
2023
Q1 | $128K | Buy |
|
|||||
|
2022
Q4 | $70K | Buy |
|
|||||
|
2022
Q3 | $87K | Buy |
|
|||||
|
2022
Q2 | $61K | Sell |
|
|||||
|
2022
Q1 | $80K | Sell |
|
|||||
|
2021
Q4 | $167K | Buy |
|
|||||
|
2021
Q3 | $194K | Sell |
|
|||||
|
2021
Q2 | $764K | Buy |
|
|||||
|
2021
Q1 | $517K | Sell |
|
|||||
|
2020
Q4 | $524K | Sell |
|
|||||
|
2020
Q3 | $892K | Buy |
|
|||||
|
2020
Q2 | $40K | Buy |
|
|||||
|
2020
Q1 | $27K | Sell |
|
|||||
|
2019
Q4 | $420K | Sell |
|
|||||
|
2019
Q3 | $381K | Sell |
|
|||||
|
2019
Q2 | $1.75M | Buy |
|
|||||
|
2019
Q1 | $1.44M | Sell |
|
|||||
|
2018
Q4 | $1.96M | Sell |
|
|||||
|
2018
Q3 | $3.27M | Sell |
|
|||||
|
2018
Q2 | $3.98M | Sell |
|
|||||
|
2018
Q1 | $3.66M | Sell |
|
|||||
|
2017
Q4 | $5.41M | Buy |
|
|||||
|
2017
Q3 | $4.06M | Buy |
|
|||||
|
2017
Q2 | $5.22M | Buy |
|
|||||
|
2017
Q1 | $1.94M | Buy |
|
|||||
|
2016
Q4 | $367K | Sell |
|
|||||
|
2016
Q3 | $1.03M | Buy |
|
|||||
|
2016
Q2 | $601K | Buy |
|
|||||
|
2016
Q1 | $477K | Buy |
|
|||||
|
2015
Q4 | $211K | Sell |
|
|||||
|
2015
Q3 | $2.36M | Buy |
|
|||||
|
2015
Q2 | $219K | Sell |
|
|||||
|
2015
Q1 | $554K | Buy |
|
|||||
|
2014
Q4 | $202K | Buy |
|
|||||
|
2014
Q3 | $20K | Sell |
|
|||||
|
2014
Q2 | $423K | Sell |
|
|||||
|
2014
Q1 | $548K | Sell |
|
|||||
|
2013
Q4 | $599K | Sell |
|
|||||
|
2013
Q3 | $2.08M | Buy |
|
|||||
|
2013
Q2 | $1.7M | Buy |
|